CAS 1164462-05-8

TG4-155

CAS: 1164462-05-8

Formula: C₂₃H₂₆N₂O₄

Purity: 99%

Color and Shape: Solid

Molecular weight: 394.4635

Ref: IN-DA0097AA

TG4-155

CAS: 1164462-05-8

TG4-155

Purity: ≥95%

Molecular weight: 394.46g/mol

Ref: 54-BUP04906

TG4-155

CAS: 1164462-05-8

TG4-155: brain-penetrant EP2 inhibitor, KB 2.4 nM; >1000x weaker at EP4, KB 11.4 μM; selective over other receptors/channels.

Formula: C₂₃H₂₆N₂O₄

Purity: 97.2%

Color and Shape: Solid

Molecular weight: 394.46

Ref: TM-T5482

TG4-155

Controlled Product

CAS: 1164462-05-8

Formula: C₂₃H₂₆N₂O₄

Color and Shape: Neat

Molecular weight: 394.46

Ref: TR-T337940

TG4-155

CAS: 1164462-05-8

TG4-155 is a low potency antiplatelet drug that is a selective antagonist for the prostacyclin receptor. It was initially developed to treat cancer, as it inhibits tumor growth and induces apoptosis in cancer cells. TG4-155 has been shown to be effective in vivo models of breast, prostate, and colon cancers. TG4-155 was also shown to reduce platelet aggregation in primary cells from ovaries and other tissues.

Formula: C₂₃H₂₆N₂O₄

Purity: Min. 95%

Molecular weight: 394.46 g/mol

Ref: 3D-PWB46205